hotspot -WSS

hotspot

author：Wikipedia 2025-10-02 01:08:04 - browse：76471

A new asthma treatment that could be administered just once every six months has succeeded in two Phase 3 trials, developer GlaxoSmithKline announced Tuesday.

The drug, depemokimab, is designed to treat asthma by targeting a protein called interleukin-5, or IL-5. The protein is linked to the type of inflammation found in most severe asthma cases, according to the pharma company.

Depemokimab hit its primary endpoints in the trials, reducing asthma attacks over a year’s time frame. The company didn’t disclose exact details from the SWIFT-1 and SWIFT-2 trials.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Oak trusses raised to roof of fire

hotspot

WSS

Key Senate committee drafts bipartisan bill to stem drug shortages

Petition to FDA: Get the lead out of consumer hair dyes

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

What to know about OceanGate, the company behind the missing Titanic submersible

Retired US general questions alleged Putin, Prigozhin meeting

Bird flu outbreak in cows is latest avian flu curveball

hotspot

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Wildfire smoke exposes gaps in outdoor worker protections

H5N1 bird flu found in pasteurized milk: what we know

Psychedelics group wrestles with new pharma identity

HCA discloses massive data breach affecting 11 million patients

State Dept. review finds Biden bears some blame for Afghanistan failures

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

United colonoscopy coverage change 'may cost lives,' doctors say

Bird flu in milk supply is likely coming from asymptomatic cows

The high cost of giving birth even with insurance

Bird flu in milk supply is likely coming from asymptomatic cows

hotspot

New research casts further doubt on a common procedure used with IVF

Charles Manson follower Leslie Van Houten released from prison after 53 years

Exact Sciences stock tumbles despite strong cancer detection sales

Petition to FDA: Get the lead out of consumer hair dyes

Dogs on Prozac: What pet anti

H5N1 bird flu virus started spreading in cows in Texas in December

focus

hotspot

explore

knowledge